TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SENTOSA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

SENTOSA

ST13

US500000079117643

Class

1, 5, 9, 10, 42

Filing

79117643

Registration

4390059

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

57

Latest update

04/13/2025

Classification

Registered

Trademark type

Word

Nice classes

1, 5, 9, 10, 42

Filing date

05/02/2012

Registration date

08/27/2013

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/29/2024

Last transaction

04/13/2025

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

4

Owner type

24

Owner location

Singapore, SG

Examiner

STEEL, ALYSSA

Law office

L70

Holders and representatives

Holders

Vela Diagnostics Holding Pte. Ltd.
Vela Holding Pte. Ltd

Representatives

Stacy L. Emhoff Walker & Jocke Co., LPA

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biological and chemical substances used in industry and for scientific and research purposes, namely, diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules

Class 5

Pharmaceutical and veterinary preparations, namely, biological substances and chemicals used for medical scientific and medical research purposes, namely, reagents and solvents for research, in particular for sample preparation, modification and manipulation of cells as well as for the performance of synthesis, amplification, labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for medical scientific and medical research purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; in-vitro diagnostic preparations for medical purposes; sanitary preparations for medical purposes

Class 9

Scientific apparatus and instruments for laboratory use, in particular for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances; scientific apparatus and instruments for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer hardware; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, for electrophoretic apparatuses, homogenizers, spectrophotometers and laboratory robots; computer software for creating experimental profiles and providing experimental reports based on sample preparation, modification and manipulation of cells as well as on synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; computer software for creating reports of apparatus performance verification, namely, for apparatuses for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances, and for apparatuses for non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer software for analyzing, displaying and visualizing experimental data and biological data, namely, polymerase chain reaction data, Real-Time-polymerase chain reaction data, and electrophoresis data

Class 10

Medical apparatus and implements, namely, apparatus and implements for the conducting and evaluation of clinical diagnostic examinations for medical purposes

Class 42

[ Scientific and technological services and research services and scientific consultancy services in the field of scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis; development of computer hardware and software for the operation and maintenance of scientific apparatus, instruments and equipment; [ development of computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; development of computer software for analyzing, displaying and visualizing experimental data and biological data ] * all of the aforementioned services only in the field of clinical, veterinary, environmental and medical diagnosis * ]

Publications

History of USPTO decisions and trademark events.

57 publications found

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

04/12/2025

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

03/13/2025

INPC

INVALIDATION PROCESSED

03/13/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

12/30/2024

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

04/29/2024

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

04/29/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/23/2024

ES71

TEAS SECTION 71 RECEIVED

08/28/2023

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

08/27/2022

RNWL

INTERNATIONAL REGISTRATION RENEWED

06/17/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/27/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

04/16/2021

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

05/07/2019

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

05/07/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/30/2019

ES75

TEAS SECTION 71 & 15 RECEIVED

04/08/2019

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/27/2018

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

02/20/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/12/2016

CHLD

CHANGE OF OWNER RECEIVED FROM IB

02/12/2016

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

01/26/2016

INPC

INVALIDATION PROCESSED

01/26/2016

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

11/09/2015

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/10/2015

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/09/2015

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

03/10/2015

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

03/09/2015

PLGL

ASSIGNED TO PARALEGAL

03/09/2015

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

03/05/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/25/2014

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/06/2013

FIMP

FINAL DISPOSITION PROCESSED

12/05/2013

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/27/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

08/27/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/11/2013

PUBO

PUBLISHED FOR OPPOSITION

06/11/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/22/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/06/2013

ALIE

ASSIGNED TO LIE

05/03/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/24/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/03/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/02/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/02/2013

RFNT

REFUSAL PROCESSED BY IB

10/26/2012

MAFR

APPLICATION FILING RECEIPT MAILED

10/05/2012

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/04/2012

RFRR

REFUSAL PROCESSED BY MPU

10/04/2012

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/04/2012

CNRT

NON-FINAL ACTION WRITTEN

10/03/2012

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

10/03/2012

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/03/2012

CNRT

NON-FINAL ACTION MAILED

10/02/2012

CNRT

NON-FINAL ACTION WRITTEN

10/02/2012

DOCK

ASSIGNED TO EXAMINER

10/01/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/01/2012

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

09/28/2012

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/28/2012

Continuous trademark protection

Get notified about every new filing that threatens SENTOSA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.